参考文献/References:
[1] TANG W H,KITAI T,HAZEN S L,et al.Gut microbiota in car-diovascular health and disease[J].Circ Res,2017,120(7):1183-1196.
[2] JI W,ZHU Y,KAN P,et al.Analysis of intestinal microbial com-munities of cerebral infarction and ischemia patients based on high throughput sequencing technology and glucose and lipid metabolism[J].Mol Med Reports,2017,16(4):5413-5417.
[3] JOVANOVICH A,ISAKOVA T,STUBBS J.Microbiome and cardi-ovascular disease in CKD[J].Clin J Am Soc Nephrol,2018,8(13):1598-1604.
[4] FU J,BONDER M J,CENIT M C,et al.The gut microbiome con-tributes to a substantial proportion of the variation in blood lipids[J].Circ Res,2015,117(9):817-824.
[5] 胡海兵,崔立,郭靓骅.基于高通量测序技术的冠心病受试者肠道菌群多样性研究[J].上海交通大学学报(农业科学版),2016,34(2):1-11.
[6] 任科雨,勇春明,金延春.青岛地区高尿酸血症受试者的肠道菌群分析[J].中国医师杂志,2014,16(12):1649-1651,1656.
[7] WANG Z J,GUO M,SI T M,et al.Association of depression with adverse cardiovascular events after percutaneous coronary intervention[J].Coron Artery Dis,2013,24(7):589-595.
[8] ANONYMOUS.The lipid research clinics coronary primary prevention trial results.I.reduction in incidence of coronary heart disease(1984)[J].JAMA,1984,251(3):351-364.
[9] ANONYMOUS.Third report of the national cholesterol education program(NCEP) expert panel on detection,evaluation,and treatment of high blood cholesterol in adults(adult treatment panel Ⅲ) final report[J].Circulation,2002,106(25):3143-3421.
[10] 袁宁,刘雅,彭春梅.冠心病受试者血尿酸水平与冠状动脉病变程度的相关性研究[J].四川医学,2017,38(12):1392-1396.
[11] 杨飞云,孔令宇,吴畏,等.青年急性心肌梗死危险因素及冠状动脉病变特点分析[J].新乡医学院学报,2018,35(4):333-339.
[12] 闫坤涛,刘寅,高静.肠道微生态与心血管疾病相关性的研究进展[J].中华心血管病杂志,2018,46(2):165-167.
[13] WANG Z,KLIPFELL E,BENNETT B J,et al.Gut flora meta-bolism of phosphatidylcholine promotes cardiovascular disease[J].Nature,2011,472(7341):57-63.
[14] KUMMEN M,MAYERHOFER C C K,VESTAD B,et al.Gut micro-biota signature in heart failure defined from profiling of 2 independent cohorts[J].J Am Coll Cardiol,2018,71(10):1184-1186.
[15] 王珊,夏耿红,何彦.氧化三甲胺分布特征及其与肠道菌群的关联性[J].南方医科大学学报,2016,36(4):455-460.
[16] KELLY T N,BAZZANO L A,AJAMI N J,et al.Gut microbiome associates with lifetime cardiovascular disease risk profile among bogalusa heart study participants[J].Circ Res,2016,119(8):956-964.
[17] CUI L,ZHAO T,HU H,et al.Association study of gut flora in coronary heart disease through high-throughput sequencing[J].Biomed Res Int,2017,2017:3796359.
[18] 周雪.瑞舒伐他汀降脂效果与人微生态菌群相关性研究[D].大连:大连医科大学,2017.
[19] 王玲,李群.冠心病受试者肠道菌群分布及其与尿酸代谢的关系分析[J].现代消化及介入诊疗,2012,17(6):327-330.
[20] 赵琼琼,沈延保,李东方.冠心病受试者尿酸代谢与肠道菌群分布的关系[J].中国病原微生物学杂志,2018,5(13):524-527.
[21] 熊文,蒋哲峰,蒋云生.双歧杆菌与乳酸杆菌在肾衰大鼠胃肠道不同部位的定植及其对小分子毒素的分解[J].中南大学学报(医学版),2009,34(1):35-39.
相似文献/References:
[1]吕风华,张素荣,张跃光,等.冠状动脉粥样硬化性心脏病合并充血性心力衰竭患者血浆脑钠肽水平的检测[J].新乡医学院学报,2007,24(06):581.
[2]廖燕.老年冠状动脉粥样硬化性心脏病患者心功能与肺动脉压和心电指标的关系[J].新乡医学院学报,2012,29(09):696.
[3]郭鹏,李继红.不同类型冠状动脉粥样硬化性心脏病患者血浆D-二聚体和纤维蛋白原水平变化[J].新乡医学院学报,2012,29(09):698.
[4]李永锋,许志强,韩 鹏,等.冠状动脉粥样硬化性心脏病合并阻塞性睡眠呼吸暂停低通气综合征的临床分析 [J].新乡医学院学报,2012,29(10):784.
[5]舒 毅,陈幼萍,曾春平,等. 2型糖尿病合并冠状动脉粥样硬化性心脏病患者下肢血管病变相关因素分析[J].新乡医学院学报,2015,32(08):785.
[6]杨亚明,赵国安,冯春瑜,等.冠状动脉粥样硬化性心脏病患者的血脂代谢机制及药物治疗研究进展[J].新乡医学院学报,2021,38(10):996.[doi:10.7683/xxyxyxb.2021.10.020]
[7]许明发,王帅飞,苏国宝,等.不同血运重建方式治疗冠状动脉粥样硬化性心脏病合并左心室功能不全的早期疗效比较[J].新乡医学院学报,2018,35(11):1018.[doi:10.7683/xxyxyxb.2018.11.018]
XU Ming-fa,WANG Shuai-fei,SU Guo-bao,et al.Comparison of early outcomes of two kinds of revascularization on the patients with coronary heart disease complicated with left ventricular dysfunction[J].Journal of Xinxiang Medical University,2018,35(7):1018.[doi:10.7683/xxyxyxb.2018.11.018]
[8]欧红萍,李 彬,周凤勤.颈动脉超声检查联合血清超敏C 反应蛋白水平检测在冠状动脉粥样硬化性心脏病诊断中的应用[J].新乡医学院学报,2014,31(10):825.[doi:10.7683/xxyxyxb.2014.10.016]
[9]王 一.冠状动脉粥样硬化性心脏病合并二尖瓣疾病和心房颤动患者同期行冠状动脉搭桥联合二尖瓣置换术和双极射频消融术疗效观察[J].新乡医学院学报,2019,36(2):155.[doi:10.7683/xxyxyxb.2019.02.013]
WANG Yi.Clinical effect of coronary artery bypass grafting and mitral valve replacement and bipolar radiofrequency ablation on the patients with coronary atherosclerotic heart disease combined with mitral valve disease and atrial fibrillation[J].Journal of Xinxiang Medical University,2019,36(7):155.[doi:10.7683/xxyxyxb.2019.02.013]
[10]刘旭辉,钱文浩,方 翔,等.不同剂量氯吡格雷对冠状动脉粥样硬化性心脏病患者凝血功能及炎症反应的影响[J].新乡医学院学报,2020,37(4):362.[doi:10.7683/xxyxyxb.2020.04.014]
LIU Xuhui,QIAN Wenhao,FANG Xiang,et al.Effects of different doses of clopidogrel on coagulation function and inflammatory response in patients with coronary atherosclerosis heart disease[J].Journal of Xinxiang Medical University,2020,37(7):362.[doi:10.7683/xxyxyxb.2020.04.014]